The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia.

Taken together, our data support the concept that the biological clock drives the expression of IL20R prompting JAK/STAT signaling and promoting LIC activity in T-ALL and suggest that the selective targeting of circadian components could be therapeutically relevant for the treatment of T-ALL patients.